| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.18 | 0.2 |